ReviewCancer drug resistance (Alhambra, Calif.)2024
Leveraging genomics, transcriptomics and epigenomics to understand chemoimmunotherapy resistance in chronic lymphocytic leukemia.
Shin Yeu Ong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.